Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Chewy shares target cut to $26 from $28, rating stays positive

EditorAhmed Abdulazez Abdulkadir
Published 2024-03-21, 10:58 a/m
© Reuters.

On Thursday, JMP Securities adjusted its price target for Chewy Inc . (NYSE:CHWY), a leading online retailer of pet products, to $26.00, a decrease from the previous target of $28.00, while retaining a Market Outperform rating on the stock. The adjustment follows Chewy's fourth-quarter earnings report, which revealed revenues slightly above consensus and an adjusted EBITDA margin that also surpassed expectations. However, the company's shares experienced a decline of approximately 3% following the announcement.

Chewy's recent financial performance demonstrated solid fourth-quarter results, with the company's top-line revenue exceeding analyst predictions and an adjusted EBITDA margin that beat the anticipated figures. Despite this, the first-quarter revenue guidance for fiscal year 2024 was somewhat below expectations, and the company anticipates its active customer growth to remain relatively stable throughout the year.

The company's guidance for fiscal year 2024's top-line revenue aligns with market expectations, and the forecasted adjusted EBITDA margin of 3.8% is higher than the estimated 3.5%. The slight downturn in Chewy's stock price post-earnings release is thought to be a reaction to the market's anticipation of more positive active customer growth trends and the company's projection of growth for fiscal year 2024 falling short of long-term goals.

Chewy's resilience is partly attributed to the nature of its sales, with approximately 85% of its net sales for fiscal year 2023 being non-discretionary and health-related. The company has also seen its autoship sales growth outperform total net sales. Moreover, Chewy is expected to see an increase in sponsored ads, which should contribute to a sequential gross margin improvement throughout the year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Expansion plans are on the horizon for Chewy, as it prepares to launch its first veterinary clinic and aims to open between four to eight clinics in fiscal year 2024, with initial sites already fully staffed.

Additionally, Chewy's foray into the Canadian market is progressing as planned, with management noting positive early results. Overall, JMP Securities views Chewy's fourth-quarter earnings positively and considers the company's current valuation an attractive opportunity for investors, despite the recent adjustment to the price target.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.